Lumira Ventures

Lumira Ventures is a prominent venture capital firm specializing in life sciences and healthcare investments. Established in 1989 and headquartered in Toronto, Canada, Lumira Ventures has a robust presence across North America, with offices in Toronto, Montreal, Vancouver, and Boston. The firm focuses on backing innovative biotechnology and medical technology companies that have the potential to address significant unmet medical needs and improve healthcare quality globally. The firm's investment portfolio includes a wide range of companies such as Depomed, Guava Technologies, Think Research, and U-Systems, showcasing their diverse interest in biopharmaceuticals and medical devices. Notable recent investments include Antiva Biosciences, developing topical therapies for HPV-related pre-cancerous lesions, and Arclight Therapeutics, focusing on neurodegenerative diseases. Lumira Ventures' investment strategy involves providing substantial support to their portfolio companies, from early-stage funding to strategic guidance. They recently closed their Lumira Ventures IV fund at $220 million, the largest life sciences venture fund ever raised in Canada, highlighting their significant role in the sector. Overall, Lumira Ventures is dedicated to advancing healthcare innovation through strategic investments and active support of pioneering companies in the life sciences domain.